Share
tweet
Aspen Pharmacare eyes Canada GLP-1 generic approval by September
Written on 04/03/2026
Janice Kew, Bloomberg
Share
tweet
Potentially giving it an early start in a key market after Novo Nordisk A/S’s Ozempic patent expired.
Read full article